Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger
Chemical Research in Toxicology · 17.08.2026 · 39 (8) · 1584-1594
DOI: 10.1021/acs.chemrestox.6c00193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 04.08.2026. Verfasst von Yuliana A Kolesnikova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Av., Tomsk634050, Russian Federation. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Drug Design, Galactosides. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Enzyme-induced cytotoxicity can be considered the main challenge in modern cancer therapy that provides unique opportunities for targeted apoptosis. To address this challenge, we implemented enzyme-triggered activation of alkoxyamine–galactose conjugates with the formation of active carbon-centered radical species for the apoptosis of cancer cells. The comparative analysis of two alkoxyamine derivatives, bearing stable and self-immolative linkers between the radical precursor and galactose moiety, revealed the crucial role of molecular structure in anticancer activity. The study of cytotoxicity and induced oxidative stress of free amine and two galactosides revealed the enzyme-dependent nature of the activity of alkoxyamines having a self-immolative linker against distinct cancer cell lines such as PC-3 (prostate adenocarcinoma), SKOV-3 (ovarian adenocarcinoma), MCF-7 (breast adenocarcinoma), A-431 (epidermoid carcinoma), and Jurkat cells (human T-lymphoblastic leukemia). The collected data prove the applicability of enzyme-triggered glycosylated alkoxyamines as a new family of targeted prodrugs against cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Av., Tomsk634050, Russian Federation.
- N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Av., Moscow119991, Russian Federation.
- Aix Marseille University, CNRS, ICR, UMR 7273, Case 551, Avenue Escadrille Normandie-Niemen, Marseille Cedex 2013397, France.
- N.N. Vorozhtsov Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Av. 9, Novosibirsk630090, Russian Federation.
ORCID-Profile: Daria D Eskova, Evgeny V Tretyakov, Sylvain R A Marque, Pavel S Postnikov, Elena V Stepanova, Pavel V Petunin
Förderung
- Russian Science Foundation
Zitieren
APA
Kolesnikova, Y. A., Abramov, A. A., Eskova, D. D., Votkina, D. E., Plotnikov, E. V., Tretyakov, E. V., Marque, S. R. A., Audran, G., Postnikov, P. S., Stepanova, E. V., & Petunin, P. V. (2026). Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger. Chemical Research in Toxicology, 39(8), 1584-1594. https://doi.org/10.1021/acs.chemrestox.6c00193
Vancouver
Kolesnikova YA, Abramov AA, Eskova DD, Votkina DE, Plotnikov EV, Tretyakov EV, et al. Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger. Chemical Research in Toxicology. 2026;39(8):1584-1594. doi:10.1021/acs.chemrestox.6c00193
BibTeX
@article{Kolesnikova2026,
author = {Kolesnikova, Yuliana A and Abramov, Alexander A and Eskova, Daria D and Votkina, Darya E and Plotnikov, Evgenii V and Tretyakov, Evgeny V and Marque, Sylvain R A and Audran, Gérard and Postnikov, Pavel S and Stepanova, Elena V and Petunin, Pavel V},
title = {Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger},
journal = {Chemical Research in Toxicology},
year = {2026},
volume = {39},
number = {8},
pages = {1584--1594},
doi = {10.1021/acs.chemrestox.6c00193}
}
EUVIMED